Pubmed ID | Gene | mRNA Expression Levels Relative to Fa2N-4 | ||||||
---|---|---|---|---|---|---|---|---|
527 | 455 | LHO | DMQ | |||||
NM_001621 | AhR | 0.21 ± 0.09* | 0.06 ± 0.02* | 0.17 ± 0.06* | 0.14 ± 0.04* | |||
NM_002015 | FOXO1A | 0.27 ± 0.04* | 0.02 ± 0.04 | 0.18 ± 0.02* | 0.62 ± 0.64 | |||
NM_178849 | HNF4α a | 0.50 ± 0.07 | 0.12 ± 0.02* | 0.30 ± 0.02* | 0.92 ± 0.14 | |||
NM_147223 | NCOA1 | 0.56 ± 0.15 | 0.29 ± 0.13* | 0.43 ± 0.08 | 0.50 ± 0.14 | |||
NM_006540 | NCOA2 a | 0.71 ± 0.04* | 0.24 ± 0.07* | 0.56 ± 0.14 | 0.54 ± 0.13 | |||
NM_181659 | NCOA3 | 0.40 ± 0.02* | 0.17 ± 0.04* | 0.42 ± 0.05 | 0.31 ± 0.08* | |||
NM_006311 | NCOR1 a | 0.28 ± 0.13* | 0.12 ± 0.01* | 0.25 ± 0.06* | 0.26 ± 0.05* | |||
NM_001077261 | NCOR2 | 0.30 ± 0.08* | 0.10 ± 0.01* | 0.32 ± 08* | 0.32 ± 0.12* | |||
NM_021969 | NROB2 a | 28.22 ± 2.17* | 14.35 ± 6.33* | 47.92 ± 2.58* | 95.50 ± 13.56* | |||
NM_007121 | NR1H2 a | 0.32 ± 0.05* | 0.12 ± 0.03* | 0.35 ± 0.06* | 0.35 ± 0.04* | |||
NM_005123 | NR1H4 a , b | 0.02 ± 0.02 | 0.01 ± 0.0* | 0.06 ± 0.07 | 0.08 ± 0.10 | |||
NM_033013 | NR1I2 | 0.71 ± 0.22 | 0.32 ± 0.11* | 0.65 ± 0.19 | 2.44 ± 0.56 | |||
NM_005122 | NR1I3 | >100c,* | >100c,* | >100c,* | 93.76 ± 43.56* | |||
NM_001018074 | NR3C1 | 0.36 ± 0.04* | 0.06 ± 0.01* | 0.31 ± 0.04* | 0.19 ± 0.04* | |||
NM_003489 | NRIP1 | 0.27 ± 0.06* | 0.19 ± 0.11* | 0.31 ± 0.24 | 0.39 ± 0.26 | |||
NM_013261 | PPARGC1A a | 0.04 ± 0.01* | 0.01 ± 0.01 | 0.06 ± 0.03* | 0.06 ± 0.02* | |||
NM_002957 | RXRA | 0.27 ± 0.05* | 0.17 ± 0.05* | 0.22 ± 0.02* | 0.61 ± 0.15 | |||
NM_000545 | TCF1 a | 0.24 ± 0.08* | 0.05 ± 0.02* | 0.18 ± 0.03* | 0.30 ± 0.01* | |||
NM_001017535 |
VDR
| 1.10 ± 0.37 | 0.14 ± 0.11 | 0.54 ± 0.13* | 0.33 ± 0.15* |
↵* P < 0.05, ΔCt value significantly different from that for Fa2N-4 cells.
↵ a Fa2N-4 cells gene expression increased > 10-fold during the 48-h adaptation period.
↵ b Cryopreserved human hepatocyte gene expression increased > 10-fold during the 24-h adaptation period.
↵ c Low gene expression in Fa2N4 cells (Ct >34).